Abstract
Sarcopenia is a multifactorial condition characterized by loss of muscle mass. It poses significant health risks in older adults worldwide. Both pharmacological and non-pharmacological approaches are reported to address this disease. Certain dietary patterns, such as adequate energy intake and essential amino acids, have shown positive outcomes in preserving muscle function. Various medications, including myostatin inhibitors, growth hormones, and activin type II receptor inhibitors, have been evaluated for their effectiveness in managing sarcopenia. However, it is important to consider the variable efficacy and potential side effects associated with these treatments. There are currently no drugs approved by the Food and Drug Administration for sarcopenia. The ongoing research aims to develop more effective strategies in the future. Our review of research on disease mechanisms and drug development will be a valuable contribution to future research endeavors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data sharing does not apply to this article as no new data were created or analyzed in this study.
References
Abe S, Ezaki O, Suzuki M (2016) Medium-chain triglycerides in combination with leucine and vitamin D Increase muscle strength and function in frail elderly adults in a randomized controlled trial. J Nutr 146:1017–1026. https://doi.org/10.3945/jn.115.228965
Adams V, Bowen TS, Werner S, Barthel P, Amberger C, Konzer A, Graumann J, Sehr P, Lewis J, Provaznik J, Benes V, Büttner P, Gasch A, Mangner N, Witt CC, Labeit D, Linke A, Labeit S (2019) Small-molecule-mediated chemical knock-down of MuRF1/MuRF2 and attenuation of diaphragm dysfunction in chronic heart failure. J Cachexia Sarcopenia Muscle 10:1102–1115. https://doi.org/10.1002/jcsm.12448
Adams V, Gußen V, Zozulya S, Cruz A, Moriscot A, Linke A, Labeit S (2020) Small-molecule chemical knockdown of MuRF1 in melanoma bearing mice attenuates tumor cachexia associated myopathy. Cells 9:2272. https://doi.org/10.3390/cells9102272
Agapova OA, Fang Y, Sugatani T, Seifert ME, Hruska KA (2016) Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease. Kidney Int 89:1231–1243. https://doi.org/10.1016/j.kint.2016.02.002
Alway SE, Mccrory JL, Kearcher K, Vickers A, Frear B, Gilleland DL, Bonner DE, Thomas JM, Donley DA, Lively MW, Mohamed JS (2017a) Resveratrol enhances exercise-induced cellular and functional adaptations of skeletal muscle in older men and women. J Gerontol Biol Sci Med Sci 72:1595–1606. https://doi.org/10.1093/gerona/glx089
Alway SE, Mohamed JS, Myers MJ (2017b) Mitochondria initiate and regulate sarcopenia. Exerc Sport Sci Rev 45:58–69. https://doi.org/10.1249/JES.0000000000000101
Amorim JA, Coppotelli G, Rolo AP, Palmeira CM, Ross JM, Sinclair DA (2022) Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat Rev Endocrinol 18:243–258. https://doi.org/10.1038/s41574-021-00626-7
Anker SD, Morley JE, Von Haehling S (2016) Welcome to the ICD-10 code for Sarcopenia. J Cachexia Sarcopenia Muscle 7:512–514. https://doi.org/10.1002/jcsm.12147
Azzout-Marniche D (2023) New insight into the understanding of muscle glycolysis: sestrins, key pivotal proteins integrating glucose and leucine to control mTOR activation. J Nutr 153:915–916. https://doi.org/10.1016/j.tjnut.202
Bagherniya M, Mahdavi A, Shokri-Mashhadi N, Banach M, Von Haehling S, Johnston TP, Sahebkar A (2022) The beneficial therapeutic effects of plant-derived natural products for the treatment of Sarcopenia. J Cachexia Sarcopenia Muscle 13:2772–2790. https://doi.org/10.1002/jcsm.13057
Barone B, Napolitano L, Abate M, Cirillo L, Reccia P, Passaro F, Turco C, Morra S, Mastrangelo F, Scarpato A, Amicuzi U, Morgera V, Romano L, Calace FP, Pandolfo SD, De Luca L, Aveta A, Sicignano E, Trivellato M, Spena G, D’alterio C, Fusco GM, Vitale R, Arcaniolo D, Crocetto F (2022) The role of testosterone in the elderly: what do we know? Int J Mol Sci 23:3535. https://doi.org/10.3390/ijms23073535
Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, Mcmurdo ME, Mets T, Seal C, Wijers SL, Ceda GP, De Vito G, Donders G, Drey M, Greig C, Holmbäck U, Narici M, Mcphee J, Poggiogalle E, Power D, Scafoglieri A, Schultz R, Sieber CC, Cederholm T (2015) Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of Sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 16:740–747. https://doi.org/10.1016/j.jamda.2015.05.021
Becker C, Lord SR, Studenski SA, Warden SJ, Fielding RA, Recknor CP, Hochberg MC, Ferrari SL, Blain H, Binder EF, Rolland Y, Poiraudeau S, Benson CT, Myers SL, Hu L, Ahmad QI, Pacuch KR, Gomez EV, Benichou O (2015) Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 3:948–957. https://doi.org/10.1016/S2213-8587(15)00298-3
Bellanti F, Lo Buglio A, Vendemiale G (2022) Muscle delivery of mitochondria-targeted drugs for the treatment of Sarcopenia: rationale and perspectives. Pharmaceutics 14:2588. https://doi.org/10.3390/pharmaceutics14122588
Bennett JL, Pratt AG, Dodds R, Sayer AA, Isaacs JD (2023) Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis. Nat Rev Rheumatol 19:239–251. https://doi.org/10.1038/s41584-023-00921-9
Birkbeck MG, Blamire AM, Whittaker RG, Sayer AA, Dodds RM (2021) The role of novel motor unit magnetic resonance imaging to investigate motor unit activity in ageing skeletal muscle. J Cachexia Sarcopenia Muscle 12:17–29. https://doi.org/10.1002/jcsm.12655
Blasco A, Gras S, Mòdol-Caballero G, Tarabal O, Casanovas A, Piedrafita L, Barranco A, Das T, Pereira SL, Navarro X, Rueda R, Esquerda JE, Calderó J (2020) Motoneuron deafferentation and gliosis occur in association with neuromuscular regressive changes during ageing in mice. J Cachexia Sarcopenia Muscle 11:1628–1660. https://doi.org/10.1002/jcsm.12599
Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420:418–421. https://doi.org/10.1038/nature01154
Bondesen BA, Mills ST, Kegley KM, Pavlath GK (2004) The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 287:C475–C483. https://doi.org/10.1152/ajpcell.00088.2004
Campbell WW, Crim MC, Dallal GE, Young VR, Evans WJ (1994) Increased protein requirements in elderly people: new data and retrospective reassessments. Am J Clin Nutr 60:501–509. https://doi.org/10.1093/ajcn/60.4.501
Cannavino J, Brocca L, Sandri M, Grassi B, Bottinelli R, Pellegrino MA (2015) The role of alterations in mitochondrial dynamics and PGC-1α over-expression in fast muscle atrophy following hindlimb unloading. J Physiol 593:1981–1995. https://doi.org/10.1113/jphysiol.2014.286740
Cao Z, Wu Y, Curry K, Wu Z, Christen Y, Luo Y (2007) Ginkgo biloba extract EGb 761 and wisconsin ginseng delay sarcopenia in caenorhabditis elegans. J Gerontol Biol Sci Med Sci 62:1337–1345. https://doi.org/10.1093/gerona/62.12.1337
Casciola R, Leoni L, Cuffari B, Pecchini M, Menozzi R, Colecchia A, Ravaioli F (2023) Creatine supplementation to improve sarcopenia in chronic liver disease: facts and perspectives. Nutrients 15:863. https://doi.org/10.3390/nu15040863
Cha RH, Kang SH, Han MY, An WS, Kim SH, Kim JC (2022) Effects of AST-120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study. J Cachexia Sarcopenia Muscle 13:397–408. https://doi.org/10.1002/jcsm.12874
Chan MC, Arany Z (2014) The many roles of PGC-1α in muscle–recent developments. Metabolism 63:441–451. https://doi.org/10.1016/j.metabol.2014.01.006
Chanet A, Verlaan S, Salles J, Giraudet C, Patrac V, Pidou V, Pouyet C, Hafnaoui N, Blot A, Cano N, Farigon N, Bongers A, Jourdan M, Luiking Y, Walrand S, Boirie Y (2017) Supplementing breakfast with a vitamin D and leucine-enriched whey protein medical nutrition drink enhances postprandial muscle protein synthesis and muscle mass in healthy older men. J Nutr 147:2262–2271. https://doi.org/10.3945/jn.117.252510
Chang YC, Chen YT, Liu HW, Chan YC, Liu MY, Hu SH, Tseng WT, Wu HL, Wang MF, Chang SJ (2019) Oligonol alleviates sarcopenia by regulation of Signaling pathways involved in protein turnover and mitochondrial quality. Mol Nutr Food Res 63:e1801102. https://doi.org/10.1002/mnfr.201801102
Chen YM, Chiu WC, Chiu YS, Li T, Sung HC, Hsiao CY (2020) Supplementation of nano-bubble curcumin extract improves gut microbiota composition and exercise performance in mice. Food Funct 11:3574–3584. https://doi.org/10.1039/C9FO02487E
Chen H, Qian Z, Zhang S, Tang J, Fang L, Jiang F, Ge D, Chang J, Cao J, Yang L, Cao X (2021) Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy. Redox Biol 38:101774. https://doi.org/10.1016/j.redox.2020.101774
Chew W, Lim YP, Lim WS, Chambers ES, Frost G, Wong SH, Ali Y (2022) Gut-muscle crosstalk. A perspective on influence of microbes on muscle function. Front Med 9:1065365. https://doi.org/10.3389/fmed.2022.1065365
Cho MR, Lee S, Song SK (2022) A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. J Korean Med Sci 37:e146. https://doi.org/10.3346/jkms.2022.37.e146
Clemens Z, Sivakumar S, Pius A, Sahu A, Shinde S, Mamiya H, Luketich N, Cui J, Dixit P, Hoeck JD, Kreuz S, Franti M, Barchowsky A, Ambrosio F (2021) The biphasic and age-dependent impact of klotho on hallmarks of aging and skeletal muscle function. eLife 10:e61138. https://doi.org/10.7554/eLife.61138
Cotton TR, Fischer G, Wang X, Mccoy JC, Czepnik M, Thompson TB, Hyvönen M (2018) Structure of the human myostatin precursor and determinants of growth factor latency. EMBO J 37:367–383. https://doi.org/10.15252/embj.201797883
Dai M, Lin T, Yue J, Dai L (2021) Signatures and clinical significance of amino acid flux in sarcopenia: a systematic review and meta-analysis. Front Endocrinol 12:725518. https://doi.org/10.3389/fendo.2021.725518
De Spiegeleer A, Wynendaele E, Descamps A, Debunne N, Braeckman BP, De Mey M, Coudenys J, Crombez L, Verbeke F, Janssens Y, Janky R, Goossens E, Vlaeminck C, Duchi D, Andries V, Dumas E, Petrovic M, Van De Wiele T, Knappe D, Hoffmann R, Mouly V, Bigot A, Vereecke L, Van Immerseel F, Van Den Noortgate N, De Spiegeleer B, Elewaut D (2022) The bacterial quorum sensing peptide iAM373 is a novel inducer of sarcopenia. Clin Transl Med 12:e1053. https://doi.org/10.1002/ctm2.1053
Deng C, Lu C, Wang K, Chang M, Shen Y, Yang X, Sun H, Yao X, Qiu C, Xu F (2024) Celecoxib ameliorates diabetic sarcopenia by inhibiting inflammation, stress response, mitochondrial dysfunction, and subsequent activation of the protein degradation systems. Front Pharmacol 15:1344276. https://doi.org/10.3389/fphar.2024.1344276
Deschenes MR (2004) Effects of aging on muscle fibre type and size. Sports Med 34:809–824. https://doi.org/10.2165/00007256-200434120-00002
Digirolamo DJ, Singhal V, Chang X, Lee SJ, Germain-Lee EL (2015) Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta. Bone Res 3:14042. https://doi.org/10.1038/boneres.2014.42
Dingemans AM, Van Walree N, Schramel F, Soud MY, Baltruškevičienė E, Lybaert W, Veldhorst M, Van Den Berg CA, Kaasa S (2023) High protein oral nutritional supplements enable the majority of Cancer patients to meet protein intake recommendations during systemic Anti-cancer treatment: a randomised controlled parallel-group study. Nutrients 15:5030. https://doi.org/10.3390/nu15245030
Dioh W, Tourette C, Del Signore S, Daudigny L, Dupont P, Balducci C, Dilda PJ, Lafont R, Veillet S (2023) A phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults. J Cachexia Sarcopenia Muscle 14:1259–1273. https://doi.org/10.1002/jcsm.13195
Dobs AS, Boccia RV, Croot CC, Gabrail NY, Dalton JT, Hancock ML, Johnston MA, Steiner MS (2013) Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol 14:335–345. https://doi.org/10.1016/S1470-2045(13)70055-X
Dowling P, Gargan S, Swandulla D, Ohlendieck K (2023) Fiber-type shifting in sarcopenia of old age: proteomic profiling of the contractile apparatus of skeletal muscles. Int J Mol Sci 24:2415. https://doi.org/10.3390/ijms24032415
Dziegala M, Josiak K, Kasztura M, Kobak K, Von Haehling S, Banasiak W, Anker SD, Ponikowski P, Jankowska E (2018) Iron deficiency as energetic insult to skeletal muscle in chronic diseases. J Cachexia Sarcopenia Muscle 9:802–815. https://doi.org/10.1002/jcsm.12314
Ebner N, Anker SD, Von Haehling S (2020) Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th cachexia conference. J Cachexia Sarcopenia Muscle 11:274–285. https://doi.org/10.1002/jcsm.12408
Ferri E, Marzetti E, Calvani R, Picca A, Cesari M, Arosio B (2020) Role of age-related mitochondrial dysfunction in sarcopenia. Int J Mol Sci 21:5236. https://doi.org/10.3390/ijms21155236
Fowler EG, Graves MC, Wetzel GT, Spencer MJ (2004) Pilot trial of albuterol in duchenne and becker muscular dystrophy. Neurology 62:1006–1008. https://doi.org/10.1212/01.WNL.0000118530.71646.0F
Gao L, Jiang J, Yang M, Hao Q, Luo L, Dong B (2015) Prevalence of sarcopenia and associated factors in Chinese community-dwelling elderly: comparison between rural and urban areas. J Am Med Dir Assoc 16:1003e1001-1003e1006. https://doi.org/10.1016/j.jamda.2015.07.020
Gharahdaghi N, Rudrappa S, Brook MS, Idris I, Crossland H, Hamrock C, Abdul Aziz MH, Kadi F, Tarum J, Greenhaff PL, Constantin-Teodosiu D, Cegielski J, Phillips BE, Wilkinson DJ, Szewczyk NJ, Smith K, Atherton PJ (2019) Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men. J Cachexia Sarcopenia Muscle 10:1276–1294. https://doi.org/10.1002/jcsm.12472
Giron M, Thomas M, Dardevet D, Chassard C, Savary-Auzeloux I (2022) Gut microbes and muscle function: can probiotics make our muscles stronger? J Cachexia Sarcopenia Muscle 13:1460–1476. https://doi.org/10.1002/jcsm.12964
Gopinath SD (2017) Inhibition of Stat3 signaling ameliorates atrophy of the soleus muscles in mice lacking the vitamin D receptor. Skelet Muscle 7:2. https://doi.org/10.1186/s13395-017-0121-2
Greenwald J, Groppe J, Gray P, Wiater E, Kwiatkowski W, Vale W, Choe S (2003) The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell 11:605–617. https://doi.org/10.1016/s1097-2765(03)00094-7
Grobet L, Martin LJ, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Ménissier F, Massabanda J, Fries R, Hanset R, Georges M (1997) A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17:71–74. https://doi.org/10.1038/ng0997-71
Gryson C, Ratel S, Rance M, Penando S, Bonhomme C, Le Ruyet P, Duclos M, Boirie Y, Walrand S (2014) Four-month course of soluble milk proteins interacts with exercise to improve muscle strength and delay fatigue in elderly participants. J Am Med Dir Assoc 15:958e951-958e959. https://doi.org/10.1016/j.jamda.2014.09.011
Gutierrez-Salmean G, Ciaraldi TP, Nogueira L, Barboza J, Taub PR, Hogan MC, Henry RR, Meaney E, Villarreal F, Ceballos G, Ramirez-Sanchez I (2014) Effects of (–)-epicatechin on molecular modulators of skeletal muscle growth and differentiation. J Nutr Biochem 25:91–94. https://doi.org/10.1016/j.jnutbio.2013.09.007
Hagiya H, Koyama T, Zamami Y, Tatebe Y, Funahashi T, Shinomiya K, Kitamura Y, Hinotsu S, Sendo T, Rakugi H, Kano MR (2019) Fall-related mortality trends in older Japanese adults aged ≥ 65 years: a nationwide observational study. BMJ open 9:e033462. https://doi.org/10.1136/bmjopen-2019-033462
Hahm JH, Nirmala FS, Ha TY, Ahn J (2023) Nutritional approaches targeting mitochondria for the prevention of Sarcopenia. Nutr Rev 20:nuad084. https://doi.org/10.1093/nutrit/nuad084
Hamauchi S, Furuse J, Takano T, Munemoto Y, Furuya K, Baba H, Takeuchi M, Choda Y, Higashiguchi T, Naito T, Muro K, Takayama K, Oyama S, Takiguchi T, Komura N, Tamura K (2019) A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer 125:4294–4302. https://doi.org/10.1002/cncr.32406
Heineke J, Auger-Messier M, Xu J, Sargent M, York A, Welle S, Molkentin JD (2010) Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation 121:419–425. https://doi.org/10.1161/CIRCULATIONAHA.109.882068
Hill A, Heyland DK, Elke G, Schaller SJ, Stocker R, Haberthür C, Von Loeffelholz C, Suchner U, Puthucheary ZA, Bear DE, Ney J, Clasen KC, Meybohm P, Lindau S, Laurentius T, Stoppe C (2020) Meeting nutritional targets of critically ill patients by combined enteral and parenteral nutrition: review and rationale for the EFFORTcombo trial. Nutr Res Rev 33:312–320. https://doi.org/10.1017/S0954422420000165
Hour TC, Vo TCT, Chuu CP, Chang HW, Su YF, Chen CH, Chen YK (2022) The promotion of migration and myogenic differentiation in skeletal muscle cells by quercetin and underlying mechanisms. Nutrients 14:4106. https://doi.org/10.3390/nu14194106
Hu SL, Chang AC, Huang CC, Tsai CH, Lin CC, Tang CH (2017) Myostatin promotes Interleukin-1β expression in rheumatoid arthritis synovial fibroblasts through inhibition of miR-21-5p. Front Immunol 8:1747. https://doi.org/10.3389/fimmu.2017.01747
Huang K, Cai HL, Bao JP, Wu LD (2020) Dehydroepiandrosterone and age-related musculoskeletal diseases: connections and therapeutic implications. Ageing Res Rev 62:101132. https://doi.org/10.1016/j.arr.2020.101132
Huang T, Liu C, Cui C, Zhang N, Cheung WH, Wong RMY (2023) Potential of fatty acids in treating sarcopenia: a systematic review. Nutrients 15:3613. https://doi.org/10.3390/nu15163613
Isanejad M, Tajik B, Mcardle A, Tuppurainen M, Sirola J, Kröger H, Rikkonen T, Erkkilä A (2022) Dietary omega-3 polyunsaturated fatty acid and alpha-linolenic acid are associated with physical capacity measure but not muscle mass in older women 65–72 years. Eur J Nutr 61:1813–1821. https://doi.org/10.1007/s00394-021-02773-z
Jackson MJ (2009) Strategies for reducing oxidative damage in ageing skeletal muscle. Adv Drug Deliv Rev 61:1363–1368. https://doi.org/10.1016/j.addr.2009.07.018
Jang JY, Kim D, Kim ND (2023) Pathogenesis, intervention, and current status of drug development for sarcopenia: a review. Biomedicines 11:1635. https://doi.org/10.3390/biomedicines11061635
Johnson M (1998) The beta-adrenoceptor. Am J Respir Crit Care Med 158:s146–s153. https://doi.org/10.1164/ajrccm.158.supplement_2.13tac110
Kaiser MS, Milan G, Ham DJ, Lin S, Oliveri F, Chojnowska K, Tintignac LA, Mittal N, Zimmerli CE, Glass DJ, Zavolan M, Rüegg MA (2022) Dual roles of mTORC1-dependent activation of the ubiquitin-proteasome system in muscle proteostasis. Commun Biol 5:1141. https://doi.org/10.1038/s42003-022-04097-y
Kambadur R, Sharma M, Smith TP, Bass JJ (1997) Mutations in myostatin (GDF8) in double-muscled belgian blue and piedmontese cattle. Genome Res 7:910–916. https://doi.org/10.1101/gr.7.9.910
Kang D, Park K, Kim D (2022) Study of therapeutic effects of losartan for sarcopenia based on the F344xBN rat aging model. Vivo 36:2740–2750. https://doi.org/10.21873/invivo.13010
Kerem L, Lawson EA (2021) The effects of oxytocin on appetite regulation, food intake and metabolism in humans. Int J Mol Sci 22:7737. https://doi.org/10.3390/ijms22147737
Kim SE, Kim DJ (2022) Sarcopenia as a prognostic indicator of liver cirrhosis. J Cachexia Sarcopenia Muscle 13:8–10. https://doi.org/10.1002/jcsm.12869
Kim H, Kim M, Kojima N, Fujino K, Hosoi E, Kobayashi H, Somekawa S, Niki Y, Yamashiro Y, Yoshida H (2016) Exercise and nutritional supplementation on community-dwelling elderly Japanese women with sarcopenic obesity: a randomized controlled trial. J Am Med Dir Assoc 17:1011–1019. https://doi.org/10.1016/j.jamda.2016.06.016
Kim JW, Kim R, Choi H, Lee SJ, Bae GU (2021) Understanding of sarcopenia: from definition to therapeutic strategies. Arch Pharm Res 44:876–889. https://doi.org/10.1007/s12272-021-01349-z
Kim JT, Roberts K, Dunlap G, Perry R, Washington T, Wolchok JC (2022) Nandrolone supplementation does not improve functional recovery in an aged animal model of volumetric muscle loss injury. J Tissue Eng Regen Med 16:367–379. https://doi.org/10.1002/term.3286
Kim HJ, Jung DW, Williams DR (2023) Age is just a number: progress and obstacles in the discovery of new candidate drugs for sarcopenia. Cells 12:2608. https://doi.org/10.3390/cells12222608
Kim KM, Yoo GD, Heo W, Oh HT, Park J, Shin S, Do Y, Jeong MG, Hwang ES, Hong JH (2023b) TAZ stimulates exercise-induced muscle satellite cell activation via Pard3-p38 MAPK-TAZ signalling axis. J Cachexia Sarcopenia Muscle 14:2733–2746. https://doi.org/10.1002/jcsm.13348
Kissel JT, Mcdermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R (2001) Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 57:1434–1440. https://doi.org/10.1212/WNL.57.8.143
Kitakaze T, Jiang H, Nomura T, Hironao KY, Yamashita Y, Ashida H (2020) Kaempferol promotes glucose uptake in myotubes through a JAK2-dependent pathway. J Agric Food Chem 68:13720–13729. https://doi.org/10.1021/acs.jafc.0c05236
Kong X, Yao T, Zhou P, Kazak L, Tenen D, Lyubetskaya A, Dawes BA, Tsai L, Kahn BB, Spiegelman BM, Liu T, Rosen ED (2018) Brown adipose tissue controls skeletal muscle function via the secretion of myostatin. Cell Metab 28:631-643e633. https://doi.org/10.1016/j.cmet.2018.07.004
Kou G, Li Z, Wu C, Liu Y, Hu Y, Guo L, Xu X, Zhou Z (2018) Citrus tangeretin improves skeletal muscle mitochondrial biogenesis via activating the AMPK-PGC1-α pathway in Vitro and in vivo: a possible mechanism for its beneficial effect on physical performance. J Agric Food Chem 66:11917–11925. https://doi.org/10.1021/acs.jafc.8b04124
Kupisz-Urbańska M, Płudowski P, Marcinowska-Suchowierska E (2021) Vitamin D deficiency in older patients-problems of sarcopenia, drug interactions, management in deficiency. Nutrients 13:1247. https://doi.org/10.3390/nu13041247
Lam CN, Watt AE, Isenring EA, De Van Der Schueren ME, Van Der Meij BS (2021) The effect of oral omega-3 polyunsaturated fatty acid supplementation on muscle maintenance and quality of life in patients with cancer: a systematic review and meta-analysis. Clin Nutr 40:3815–3826. https://doi.org/10.1016/j.clnu.2021.04.031
Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, Bernabei R, Onder G (2013) Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 42:203–209. https://doi.org/10.1093/ageing/afs194
Latres E, Pangilinan J, Miloscio L, Bauerlein R, Na E, Potocky TB, Huang Y, Eckersdorff M, Rafique A, Mastaitis J, Lin C, Murphy AJ, Yancopoulos GD, Gromada J, Stitt T (2015) Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. Skelet Muscle 5:34. https://doi.org/10.1186/s13395-015-0060-8
Latres E, Mastaitis J, Fury W, Miloscio L, Trejos J, Pangilinan J, Okamoto H, Cavino K, Na E, Papatheodorou A, Willer T, Bai Y, Hae Kim J, Rafique A, Jaspers S, Stitt T, Murphy AJ, Yancopoulos GD, Gromada J (2017) Activin A more prominently regulates muscle mass in primates than does GDF8. Nat Commun 8:15153. https://doi.org/10.1038/ncomms15153
Lee JY, Shin SK, Bae HR, Ji Y, Park HJ, Kwon EY (2023) The animal protein hydrolysate attenuates Sarcopenia via the muscle-gut axis in aged mice. Biomed Pharmacother 167:115604. https://doi.org/10.1016/j.biopha.2023.115604
Liang H, Wang O, Cheng Z, Xia P, Wang L, Shen J, Kong X, Zeng Y, Chao A, Yan L, Lin H, Sun H, Cheng Q, Zhu M, Hu Z, Zhang Z, Tang H, Xia W (2022) Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: a randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial. J Orthop Translat 35:53–61. https://doi.org/10.1016/j.jot.2022.05.002
Liu L, Charville GW, Cheung TH, Yoo B, Santos PJ, Schroeder M, Rando TA (2018) Impaired notch signaling leads to a decrease in p53 activity and mitotic catastrophe in aged muscle stem cells. Cell Stem Cell 23:544-556e544. https://doi.org/10.1016/j.stem.2018.08.019
Liu S, Zhang L, Li S (2023) Advances in nutritional supplementation for sarcopenia management. Front Nutr 10:1189522. https://doi.org/10.3389/fnut.2023.1189522
Livshits G, Kalinkovich A (2023) A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated Sarcopenia and obesity. Ageing Res Rev 86:101852. https://doi.org/10.1016/j.arr.2023.101852
Malafarina V, Uriz-Otano F, Malafarina C, Martinez JA, Zulet MA (2017) Effectiveness of nutritional supplementation on sarcopenia and recovery in hip fracture patients. A multi-centre randomized trial. Maturitas 101:42–50. https://doi.org/10.1016/j.maturitas.2017.04.010
Mancin L, Wu GD, Paoli A (2023) Gut microbiota-bile acid-skeletal muscle axis. Trends Microbiol 31:254–269. https://doi.org/10.1016/j.tim.2022.10.003
Mankhong S, Kim S, Moon S, Lee JS, Cho EJ, Kwak HB, Park DH, Ryu JK, Kang JH (2023) Melatonin and exercise counteract sarcopenic obesity through preservation of satellite cell function. Int J Mol Sci 24:6097. https://doi.org/10.3390/ijms24076097
March DS, Wilkinson TJ, Burnell T, Billany RE, Jackson K, Baker LA, Thomas A, Robinson KA, Watson EL, Graham-Brown MPM, Jones AW, Burton JO (2022) The effect of non-pharmacological and pharmacological interventions on measures Associated with Sarcopenia in end-stage kidney disease: a systematic review and Meta-analysis. Nutrients 14:1817. https://doi.org/10.3390/nu14091817
Martínez-Arnau FM, Fonfría-Vivas R, Buigues C, Castillo Y, Molina P, Hoogland AJ, Van Doesburg F, Pruimboom L, Fernández-Garrido J, Cauli O (2020) Effects of leucine administration in sarcopenia: a randomized and placebo-controlled clinical trial. Nutrients 12:932. https://doi.org/10.3390/nu12040932
Maruti SS, Ulrich CM, White E (2009) Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr 89:624–633. https://doi.org/10.3945/ajcn.2008.26568
Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, Vasileva E, Levshina A, Kozlov E, Ivashkin V (2023) Sarcopenia in cirrhosis: prospects for therapy targeted to gut microbiota. World J Gastroenterol 29:4236–4251. https://doi.org/10.3748/wjg.v29.i27.4236
Mccroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R (2003) Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162:1135–1147. https://doi.org/10.1083/jcb.200207056
Mclean RR, Kiel DP (2015) Developing consensus criteria for sarcopenia: an update. J Bone Min Res 30:588–592. https://doi.org/10.1002/jbmr.2492
Mcpherron AC, Lee SJ (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109:595–601. https://doi.org/10.1172/JCI13562
Mcpherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83–90. https://doi.org/10.1038/387083a0
Miedany YE, Gaafary ME, Toth M, Hegazi MO, Aroussy NE, Hassan W, Almedany S, Nasr A, Bahlas S, Galal S (2021) Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia? Clin Rheumatol 40:4225–4232. https://doi.org/10.1007/s10067-021-05757-w
Mizuno T, Hosoyama T, Tomida M, Yamamoto Y, Nakamichi Y, Kato S, Kawai-Takaishi M, Ishizuka S, Nishita Y, Tange C, Shimokata H, Imagama S, Otsuka R (2022) Influence of vitamin D on sarcopenia pathophysiology: a longitudinal study in humans and basic research in knockout mice. J Cachexia Sarcopenia Muscle 13:2961–2973. https://doi.org/10.1002/jcsm.13102
Montesano A, Luzi L, Senesi P, Mazzocchi N, Terruzzi I (2013) Resveratrol promotes myogenesis and hypertrophy in murine myoblasts. J Transl Med 11:310. https://doi.org/10.1186/1479-5876-11-310
Montiel-Rojas D, Nilsson A, Santoro A, Bazzocchi A, De Groot L, Feskens EJM, Berendsen AM, Madej D, Kaluza J, Pietruszka B, Jennings A, Fairweather-Tait S, Battista G, Capri M, Franceschi C, Kadi F (2020) Fighting sarcopenia in ageing european adults: the importance of the amount and source of dietary proteins. Nutrients 12:3601. https://doi.org/10.3390/nu12123601
Moon JH, Koo BK, Kim W (2021) Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey. J Cachexia Sarcopenia Muscle 12:964–972. https://doi.org/10.1002/jcsm.12719
Mori H, Tokuda Y (2022) De-training effects following leucine-enriched whey protein supplementation and resistance training in older adults with sarcopenia: a randomized controlled trial with 24 weeks of Follow-Up. J Nutr Health Aging 26:994–1002. https://doi.org/10.1007/s12603-022-1853-1
Morvan F, Rondeau JM, Zou C, Minetti G, Scheufler C, Scharenberg M, Jacobi C, Brebbia P, Ritter V, Toussaint G, Koelbing C, Leber X, Schilb A, Witte F, Lehmann S, Koch E, Geisse S, Glass DJ, Lach-Trifilieff E (2017) Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy. Proc Natl Acad Sci USA 114:12448–12453. https://doi.org/10.1073/pnas.1707925114
Munguia L, Rubio-Gayosso I, Ramirez-Sanchez I, Ortiz A, Hidalgo I, Gonzalez C, Meaney E, Villarreal F, Najera N, Ceballos G (2019) High flavonoid cocoa supplement ameliorates plasma oxidative stress and inflammation levels while improving mobility and quality of life in older subjects: a double-blind randomized clinical trial. J Gerontol Biol Sci Med Sci 74:1620–1627. https://doi.org/10.1093/gerona/glz107
Nardone OM, De Sire R, Petito V, Testa A, Villani G, Scaldaferri F, Castiglione F (2021) Inflammatory bowel diseases and sarcopenia: the role of inflammation and gut microbiota in the development of muscle failure. Front Immunol 12:694217. https://doi.org/10.3389/fimmu.2021.694217
Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO (2008) Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med 149:601–611. https://doi.org/10.7326/0003-4819-149-9-200811040-0000
Nilsson MI, Mikhail A, Lan L, Di Carlo A, Hamilton B, Barnard K, Hettinga BP, Hatcher E, Tarnopolsky MG, Nederveen JP, Bujak AL, May L, Tarnopolsky MA (2020) A five-ingredient nutritional supplement and home-based resistance exercise improve lean mass and strength in free-living elderly. Nutrients 12:2391. https://doi.org/10.3390/nu12082391
Nuccio A, Nogueira-Ferreira R, Moreira-Pais A, Attanzio A, Duarte JA, Luparello C, Ferreira R (2024) The contribution of mitochondria to age-related skeletal muscle wasting: a sex-specific perspective. Life Sci 336:122324. https://doi.org/10.1016/j.lfs.2023.122324
Oh H-J, Jin H, Lee B-Y (2022) The non-saponin fraction of Korean red ginseng ameliorates sarcopenia by regulating immune homeostasis in 22–26-month-old C57BL/6J mice. J Ginseng Res 46:809–818. https://doi.org/10.1016/j.jgr.2022.05.007
Ottens F, Franz A, Hoppe T (2021) Build-UPS and break-downs: metabolism impacts on proteostasis and aging. Cell Death Differ 28:505–521. https://doi.org/10.1038/s41418-020-00682-y
Papanicolaou DA, Ather SN, Zhu H, Zhou Y, Lutkiewicz J, Scott BB, Chandler J (2013) A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J Nutr Health Aging 17:533–543. https://doi.org/10.1007/s12603-013-0335-x
Park MJ, Choi KM (2023) Interplay of skeletal muscle and adipose tissue: sarcopenic obesity. Metabolism 144:155577. https://doi.org/10.1016/j.metabol.2023.155577
Peris-Moreno D, Cussonneau L, Combaret L, Polge C, Taillandier D (2021) Ubiquitin ligases at the heart of skeletal muscle atrophy control. Molecules 26:407. https://doi.org/10.3390/molecules26020407
Petermann-Rocha F, Gray SR, Pell JP, Ho FK, Celis-Morales C (2021) The joint association of sarcopenia and frailty with incidence and mortality health outcomes: a prospective study. Clin Nutr 40:2427–2434. https://doi.org/10.1016/j.clnu.2020.10.044
Piasecki M, Ireland A, Piasecki J, Stashuk DW, Swiecicka A, Rutter MK, Jones DA, Mcphee JS (2018) Failure to expand the motor unit size to compensate for declining motor unit numbers distinguishes sarcopenic from non-sarcopenic older men. J Physiol 596:1627–1637. https://doi.org/10.1113/JP275520
Pietra C, Takeda Y, Tazawa-Ogata N, Minami M, Yuanfeng X, Duus EM, Northrup R (2014) Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile. J Cachexia Sarcopenia Muscle 5:329–337. https://doi.org/10.1007/s13539-014-0159-5
Piovezan RD, Abucham J, Dos Santos RV, Mello MT, Tufik S, Poyares D (2015) The impact of sleep on age-related Sarcopenia: possible connections and clinical implications. Ageing Res Rev 23:210–220. https://doi.org/10.1016/j.arr.2015.07.003
Polyzos SA, Mantzoros CS (2024) Sarcopenia: still in relative definition-penia and severe treatment-penia. Metabolism 150:155717. https://doi.org/10.1016/j.metabol.2023.155717
Powell EE, Wong VW, Rinella M (2021) Non-alcoholic fatty liver disease. Lancet 397:2212–2224. https://doi.org/10.1016/S0140-6736(20)32511-3
Qiu J, Thapaliya S, Runkana A, Yang Y, Tsien C, Mohan ML, Narayanan A, Eghtesad B, Mozdziak PE, Mcdonald C, Stark GR, Welle S, Naga Prasad SV, Dasarathy S (2013) Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism. Proc Natl Acad Sci USA 110:18162–18167. https://doi.org/10.1073/pnas.1317049110
Ranjit R, Van Remmen H, Ahn B (2022) Acylated ghrelin receptor agonist HM01 decreases lean body and muscle Mass, but unacylated ghrelin protects against redox-dependent sarcopenia. Antioxidants 11:2358. https://doi.org/10.3390/antiox11122358
Ray Hamidie RD, Yamada T, Ishizawa R, Saito Y, Masuda K (2015) Curcumin treatment enhances the effect of exercise on mitochondrial biogenesis in skeletal muscle by increasing cAMP levels. Metabolism 64:1334–1347. https://doi.org/10.1016/j.metabol.2015.07.010
Reichelt S, Pratschke J, Engelmann C, Neumann UP, Lurje G, Czigany Z (2022) Body composition and the skeletal muscle compartment in liver transplantation: turning challenges into opportunities. Am J Transpl 22:1943–1957. https://doi.org/10.1111/ajt.17089
Reid MB, Stokić DS, Koch SM, Khawli FA, Leis AA (1994) N-acetylcysteine inhibits muscle fatigue in humans. J Clin Invest 94:2468–2474. https://doi.org/10.1172/JCI117615
Robinson SM, Reginster JY, Rizzoli R, Shaw SC, Kanis JA, Bautmans I, Bischoff-Ferrari H, Bruyère O, Cesari M, Dawson-Hughes B, Fielding RA, Kaufman JM, Landi F, Malafarina V, Rolland Y, Van Loon LJ, Vellas B, Visser M, Cooper C (2018) Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr 37:1121–1132. https://doi.org/10.1016/j.clnu.2017.08.016
Robinson S, Granic A, Sayer AA (2021) Micronutrients and sarcopenia: current perspectives. Proc Nutr Soc 80:311–318. https://doi.org/10.1017/S0029665121001956
Romani M, Berger MM, D’amelio P (2022) From the bench to the bedside: branched amino acid and micronutrient strategies to improve mitochondrial dysfunction leading to sarcopenia. Nutrients 14:483. https://doi.org/10.3390/nu14030483
Rondanelli M, Klersy C, Terracol G, Talluri J, Maugeri R, Guido D, Faliva MA, Solerte BS, Fioravanti M, Lukaski H, Perna S (2016) Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am J Clin Nutr 103:830–840. https://doi.org/10.3945/ajcn.115.113357
Rooks D, Praestgaard J, Hariry S, Laurent D, Petricoul O, Perry RG, Lach-Trifilieff E, Roubenoff R (2017a) Treatment of sarcopenia with bimagrumab: results from a phase ii, randomized, controlled, proof-of-concept study. J Am Geriatr Soc 65:1988–1995. https://doi.org/10.1111/jgs.14927
Rooks DS, Laurent D, Praestgaard J, Rasmussen S, Bartlett M, Tankó LB (2017b) Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy. J Cachexia Sarcopenia Muscle 8:727–734. https://doi.org/10.1002/jcsm.12205
Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N, Coleman LA, Miller RR, Garcia Garayoa E, Praestgaard J, Perry RG, Recknor C, Fogarty CM, Arai H, Chen LK, Hashimoto J, Chung YS, Vissing J, Laurent D, Petricoul O, Hemsley S, Lach-Trifilieff E, Papanicolaou DA, Roubenoff R (2020) Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial. JAMA Netw Open 3:e2020836. https://doi.org/10.1001/jamanetworkopen.2020.20836
Roschel H, Hayashi AP, Fernandes AL, Jambassi-Filho JC, Hevia-Larraín V, De Capitani M, Santana DA, Gonçalves LS, De Sá-Pinto AL, Lima FR, Sapienza MT, Duarte AJS, Pereira RMR, Phillips SM, Gualano B (2021) Supplement-based nutritional strategies to tackle frailty: a multifactorial, double-blind, randomized placebo-controlled trial. Clin Nutr 40:4849–4858. https://doi.org/10.1016/j.clnu.2021.06.024
Ryall JG, Sillence MN, Lynch GS (2006) Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. Br J Pharmacol 147:587–595. https://doi.org/10.1038/sj.bjp.0706669
Rybchyn MS, Abboud M, Puglisi DA, Gordon-Thomson C, Brennan-Speranza TC, Mason RS, Fraser DR (2020) Skeletal muscle and the maintenance of vitamin D status. Nutrients 12:3270. https://doi.org/10.3390/nu12113270
Sánchez-Sánchez JL, Mañas A, García-García FJ, Ara I, Carnicero JA, Walter S, Rodríguez-Mañas L (2019) Sedentary behaviour, physical activity, and Sarcopenia among older adults in the TSHA: isotemporal substitution model. J Cachexia Sarcopenia Muscle 10:188–198. https://doi.org/10.1002/jcsm.12369
Sartori R, Romanello V, Sandri M (2021) Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat Commun 12:330. https://doi.org/10.1038/s41467-020-20123-1
Saud Gany SL, Tan JK, Chin KY, Hakimi NH, Ab Rani N, Ihsan N, Makpol S (2022) Untargeted muscle tissue metabolites profiling in young, adult, and old rats supplemented with tocotrienol-rich fraction. Front Mol Biosci 9:1008908. https://doi.org/10.3389/fmolb.2022.1008908
Shang M, Cappellesso F, Amorim R, Serneels J, Virga F, Eelen G, Carobbio S, Rincon MY, Maechler P, De Bock K, Ho PC, Sandri M, Ghesquière B, Carmeliet P, Di Matteo M, Berardi E, Mazzone M (2020) Macrophage-derived glutamine boosts satellite cells and muscle regeneration. Nature 587:626–631. https://doi.org/10.1038/s41586-020-2857-9
Shigehara K, Kato Y, Izumi K, Mizokami A (2022) Relationship between testosterone and sarcopenia in older-adult men: a narrative review. J clin Med. https://doi.org/10.3390/jcm11206202
Sica RE, Mccomas AJ (1971) Fast and slow twitch units in a human muscle. J Neurol Neurosurg Psychiatry 34:113–120. https://doi.org/10.1136/jnnp.34.2.113
Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Resnick SM, Budoff M, Mohler ER III, Wenger NK, Cohen HJ, Schrier S, Keaveny TM, Kopperdahl D, Lee D, Cifelli D, Ellenberg SS (2018) Lessons from the testosterone trials. Endocr Rev 39:369–386. https://doi.org/10.1210/er.2017-00234
So HK, Kim H, Lee J, You CL, Yun CE, Jeong HJ, Jin EJ, Jo Y, Ryu D, Bae GU, Kang JS (2023) Protein arginine methyltransferase 1 ablation in motor neurons causes mitochondrial dysfunction leading to age-related motor neuron degeneration with muscle loss. Research 6:0158. https://doi.org/10.34133/research.0158
Solis-Cohen S (1900) The use of adrenal substance in the treatment of asthma. J Asthma 27:401–406. https://doi.org/10.1001/jama.1900.24610190014001c
Sousa-Victor P, García-Prat L, Muñoz-Cánoves P (2022) Control of satellite cell function in muscle regeneration and its disruption in ageing. Nat Rev Mol Cell Biol 23:204–226. https://doi.org/10.1038/s41580-021-00421-2
Sriram S, Subramanian S, Sathiakumar D, Venkatesh R, Salerno MS, Mcfarlane CD, Kambadur R, Sharma M (2011) Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB. Aging Cell 10:931–948. https://doi.org/10.1111/j.1474-9726.2011.00734.x
Suh J, Lee YS (2020) Myostatin inhibitors: panacea or predicament for musculoskeletal disorders? J Bone Metab 27:151–165.https://doi.org/10.11005/jbm.2020.27.3.151
Supriya R, Singh KP, Gao Y, Gu Y, Baker JS (2021) Effect of Exercise on secondary Sarcopenia: a Comprehensive Literature Review. Biology 11:51. https://doi.org/10.3390/biology11010051
Takagi A, Hawke P, Tokuda S, Toda T, Higashizono K, Nagai E, Watanabe M, Nakatani E, Kanemoto H, Oba N (2022) Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients. J Cachexia Sarcopenia Muscle 13:287–295. https://doi.org/10.1002/jcsm.12906
Tan LJ, Liu SL, Lei SF, Papasian CJ, Deng HW (2012) Molecular genetic studies of gene identification for Sarcopenia. Hum Genet 131:1–31. https://doi.org/10.1007/s00439-011-1040-7
Tang H, Shrager JB, Goldman D (2019) Rapamycin protects aging muscle. Aging 11:5868–5870. https://doi.org/10.18632/aging.102176
Tao W, Ouyang Z, Liao Z, Li L, Zhang Y, Gao J, Ma L, Yu S (2023) Ursolic acid alleviates cancer cachexia and prevents muscle wasting via activating SIRT1. Cancers 15:2378. https://doi.org/10.3390/cancers15082378
Thomas FP, Brannagan TH III, Butterfield RJ, Desai U, Habib AA, Herrmann DN, Eichinger KJ, Johnson NE, Karam C, Pestronk A, Quinn C, Shy ME, Statland JM, Subramony SH, Walk D, Stevens-Favorite K, Miller B, Leneus A, Fowler M, Van De Rijn M, Attie KM (2022) Randomized phase 2 study of ACE-083 in patients with charcot-marie-tooth disease. Neurology 98:e2356–e2367. https://doi.org/10.1212/WNL.0000000000200325
Tieland M, Trouwborst I, Clark BC (2018) Skeletal muscle performance and ageing. J Cachexia Sarcopenia Muscle 9:3–19. https://doi.org/10.1002/jcsm.12238
Trappe TA, Carroll CC, Dickinson JM, Lemoine JK, Haus JM, Sullivan BE, Lee JD, Jemiolo B, Weinheimer EM, Hollon CJ (2011) Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. Am J Physiol Regul Integr Comp Physiol 300:R655–R662. https://doi.org/10.1152/ajpregu.00611.2010
Uchitomi R, Oyabu M, Kamei Y (2020) Vitamin D and sarcopenia: potential of vitamin D supplementation in sarcopenia prevention and treatment. Nutrients 12:3189. https://doi.org/10.3390/nu12103189
Vainshtein A, Sandri M (2020) Signaling pathways that control muscle mass. Int J Mol Sci 21:4759. https://doi.org/10.3390/ijms21134759
Varma K, Amalraj A, Divya C, Gopi S (2021) The efficacy of the novel bioavailable curcumin (Cureit) in the management of sarcopenia in healthy elderly subjects: a randomized, placebo-controlled, double-blind clinical study. J Med Food 24:40–49. https://doi.org/10.1089/jmf.2020.4778
Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S (2012) Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 11:851–859. https://doi.org/10.1016/S1474-4422(12)70206-5
Vitale P, Panella A, Scilimati A, Perrone MG (2016) COX-1 inhibitors: beyond structure toward therapy. Med Res Rev 36:641–671. https://doi.org/10.1002/med.21389
Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR (2008) A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63:561–571. https://doi.org/10.1002/ana.21338
Wall BT, Van Loon LJ (2013) Nutritional strategies to attenuate muscle disuse atrophy. Nutr Rev 71:195–208. https://doi.org/10.1111/nure.12019
Wang J, Fröhlich H, Torres FB, Silva RL, Poschet G, Agarwal A, Rappold GA (2022) Mitochondrial dysfunction and oxidative stress contribute to cognitive and motor impairment in FOXP1 syndrome. Proc Natl Acad Sci U S A 119:e2112852119. https://doi.org/10.1073/pnas.2112852119
Wang T, Xu H, Wu S, Guo Y, Zhao G, Wang D (2023) Mechanisms underlying the effects of the green tea polyphenol EGCG in sarcopenia prevention and management. J Agric Food Chem 71:9609–9627. https://doi.org/10.1021/acs.jafc.3c02023
Wannamethee SG, Atkins JL (2015) Muscle loss and obesity: the health implications of Sarcopenia and sarcopenic obesity. Proc Nutr Soc 74:405–412. https://doi.org/10.1017/S002966511500169X
Wijaya YT, Setiawan T, Sari IN, Park K, Lee CH, Cho KW, Lee YK, Lim JY, Yoon JK, Lee SH, Kwon HY (2022) Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway. J Cachexia Sarcopenia Muscle 13:3149–3162. https://doi.org/10.1002/jcsm.13084
Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, Malluche HH, Hruska KA (2018) The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney Int 93:147–158. https://doi.org/10.1016/j.kint.2017.06.016
Witham MD, Clarke CL, Hutcheon A, Gingles C, Gandy S, Priba L, Nicholas RS, Cavin I, Sumukadas D, Struthers AD, George J (2020) Effect of allopurinol on phosphocreatine recovery and muscle function in older people with impaired physical function: a randomised controlled trial. Age Ageing 49:1003–1010. https://doi.org/10.1093/ageing/afaa061
Wolfman NM, Mcpherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN, Wright JF, Zhao L, Sebald SM, Greenspan DS, Lee SJ (2003) Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A 100:15842–15846. https://doi.org/10.1073/pnas.2534946100
Wyke SM, Russell ST, Tisdale MJ (2004) Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. Br J Cancer 91:1742–1750. https://doi.org/10.1038/sj.bjc.6602165
Yang J, Jiang F, Yang M, Chen Z (2022) Sarcopenia and nervous system disorders. J Neurol 269:5787–5797. https://doi.org/10.1007/s00415-022-11268-8
Yeo D, Kang C, Gomez-Cabrera MC, Vina J, Ji LL (2019) Intensified mitophagy in skeletal muscle with aging is downregulated by PGC-1alpha overexpression in vivo. Free Radic Biol Med 130:361–368. https://doi.org/10.1016/j.freeradbiomed.2018.10.456
Yoo JI, Kim JT, Park CH, Cha Y (2022) Diagnosis and management of Sarcopenia after hip fracture surgery: current concept review. Hip Pelvis 34:1–9. https://doi.org/10.5371/hp.2022.34.1.1
Yoshimura Y, Bise T, Shimazu S, Tanoue M, Tomioka Y, Araki M, Nishino T, Kuzuhara A, Takatsuki F (2019) Effects of a leucine-enriched amino acid supplement on muscle mass, muscle strength, and physical function in post-stroke patients with Sarcopenia: a randomized controlled trial. Nutrition 58:1–6. https://doi.org/10.1016/j.nut.2018.05.028
Zanders L, Kny M, Hahn A, Schmidt S, Wundersitz S, Todiras M, Lahmann I, Bandyopadhyay A, Wollersheim T, Kaderali L, Luft FC, Birchmeier C, Weber-Carstens S, Fielitz J (2022) Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting. J Cachexia Sarcopenia Muscle 13:713–727. https://doi.org/10.1002/jcsm.12867
Zanotti E, Felicetti G, Maini M, Fracchia C (2003) Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest 124:292–296. https://doi.org/10.1378/chest.124.1.292
Zhang L, Pan J, Dong Y, Tweardy DJ, Dong Y, Garibotto G, Mitch WE (2013) Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass. Cell Metab 18:368–379. https://doi.org/10.1016/j.cmet.2013.07.012
Zhang H, Chi M, Chen L, Sun X, Wan L, Yang Q, Guo C (2021) Daidzein alleviates cisplatin-induced muscle atrophy by regulating Glut4/AMPK/FoxO pathway. Phytother Res 35:4363–4376. https://doi.org/10.1002/ptr.7132
Zhao J, Huang Y, Yu X (2022) Effects of nutritional supplement and resistance training for sarcopenia in patients with inflammatory bowel disease: a randomized controlled trial. Medicine 101:e30386. https://doi.org/10.1097/MD.0000000000030386
Zheng Y, Yu Y, Feng J, Ling M, Wang X (2024) Unveiling the potential of nelumbo nucifera-derived liensinine to target the myostatin protein and to counteract muscle atrophy. J Agric Food Chem 72:2240–2249. https://doi.org/10.1021/acs.jafc.3c09002
Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, Rosenfeld R, Chen Q, Boone T, Simonet WS, Lacey DL, Goldberg AL, Han HQ (2010) Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142:531–543. https://doi.org/10.1016/j.cell.2010.07.011
Zhou S, Kalds P, Luo Q, Sun K, Zhao X, Gao Y, Cai B, Huang S, Kou Q, Petersen B, Chen Y, Ma B, Wang X (2022) Optimized Cas9:sgRNA delivery efficiently generates biallelic MSTN knockout sheep without affecting meat quality. BMC Genomics 23:348. https://doi.org/10.1186/s12864-022-08594-6
Zhu LY, Chan R, Kwok T, Cheng KC, Ha A, Woo J (2019) Effects of exercise and nutrition supplementation in community-dwelling older Chinese people with sarcopenia: a randomized controlled trial. Age Ageing 48:220–228. https://doi.org/10.1093/ageing/afy179
Acknowledgements
This work was supported by the Major Special Science and Technology Plan (202302AA310020) and the National Natural Science Foundation of China (NSFC) (32072925).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zheng, Y., Feng, J., Yu, Y. et al. Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies. Arch. Pharm. Res. 47, 301–324 (2024). https://doi.org/10.1007/s12272-024-01493-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-024-01493-2